Muscarinic versus nicotinic modulation of a visual task: A PET study using drug probes

Neuropsychopharmacology

Volumn 25, Issue 4, 2001, Pages 555-564

  Mentis, Marc J ^a,c   Sunderland, Trey ^b   Lai, Jennifer ^b   Connolly, Catherine ^b   Krasuski, Jack ^a   Levine, Barbara ^a   Friz, Judy ^b   Sobti, Sandeep ^a   Schapiro, Mark ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Acetylcholine; Anticholinesterase; Brain; Human; Muscarinic blocker; Oxygen isotopes; PET scan; Photic stimulation; Physostigmine; Regional blood flow; Scopolamine; Visual cortex

Indexed keywords

ACETYLCHOLINE; GLYCOPYRRONIUM BROMIDE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PHYSOSTIGMINE; SCOPOLAMINE;

ADULT; AGED; ARTICLE; ASSOCIATION CORTEX; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN REGION; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG TOLERANCE; FEMALE; HUMAN; MALE; MODULATION; NAUSEA; NEUROPSYCHOLOGY; NORMAL HUMAN; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULSE RATE; STRIATE CORTEX; URINE RETENTION; VISION; VISUAL STIMULATION; VOMITING;

AGED; ATTENTION; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PHYSOSTIGMINE; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SCOPOLAMINE; TOMOGRAPHY, EMISSION-COMPUTED; VISUAL PERCEPTION;

EID: 17944382818     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00264-0     Document Type: Article

References (52)

1. Basal forebrain neurons modulate cortical cerebral blood flow: Increases by nicotinic cholinergic mechanism
2. The effects of scopolamine on changes in regional cerebral blood flow during classical conditioning of the human eyeblink response
3. Synergistic effects of unilateral immunolesions of the cholinergic projections from the basal forebrain and contralateral ablations of the inferotemporal cortex and hippocampus in monkeys
4. Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats
5. Evaluating storage, retention, and retrieval in disordered memory and learning
6. Tomographic measurement of LCBF with high-resolution PET and H215O: Comparison of methods
7. Nicotinic receptors in mammalian brain: Localization and relation to cholinergic innervation
8. The metabolic brain pattern of young subjects given scopolamine
9. Distribution of nicotinic receptors in the CNS
10. Autoradiographic localization of muscarinic cholinergic receptors in visual areas of cat brain: Variations in sensitivity of N-[3H]methylscopolamine binding sites to carbachol and pirenzepine
11. Neural mechanisms of visual processing in monkeys
12. Extended tables of the percentage points of student's t-distribution
13. Distributed hierarchical processing in the primate cerebral cortex
14. Assessing the significance of focal activations using their spatial extent
15. Cholinergic systems and related neuropathological predilection patterns in Alzheimer Disease
16. Changes in regional cerebral blood flow (rCBF) demonstrate separate visual pathways for object discrimination and spatial location
17. The effect of the muscarinic antagonist scopolamine on regional cerebral blood flow during performance of a memory task
18. Cerebral blood flow using PET measurements of fluoromethane kinetics
19. Review: Does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI
20. The neural basis of perception and movement
21. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor
22. Psychophysical evidence for separate channels for the perception of form, color, movement and depth
23. Nicotine enhances cerebral glucose utilization in central components of the rat visual system
24. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits
25. The localization of cholinergic neurons and markers in the CNS
26. Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex
27. Central visual pathways
28. Two types of muscarinic response to acetylcholine in mammalian cortical neurons
29. On analyzing and interpreting PET activation data in the presence of significant and biologically meaningful group global mean differences
30. Frequency variation of a pattern-flash visual stimulus during PET differentially activates brain from striate through frontal cortex
31. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation
32. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET
33. Acetylcholine-induced inhibition in the cat visual cortex is mediated by a GABAergic mechanism
34. Neuronal nicotinic receptors in the human brain
35. An approximate normalization of the analysis of variance distribution
36. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain
37. Attentional networks
38. Distribution of muscarinic acetylcholine receptors in the CNS
39. Regional brain activity during shape recognition impaired by a scopolamine channenge to encoding
40. Cholinergic neural regulation of regional cerebral blood flow
41. Effects of cholinergic depletion on neuron activities in the cat visual cortex
42. A functional role of cholinergic innervation to neurons in the cat visual cortex
43. Muscarinic acetylcholine receptor subtypes in rat visual cortex - A comparative study using quantitative receptor autoradiography and in situ hybridization
44. Cholinergic modulation of the functional organization of the cat visual cortex
45. Modulatory and inhibitory processes in the visual cortex
46. Nicotinic receptor distribution in the human thalamus: Autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding
47. Subclassification of muscarinic receptors based upon the selective antagonist pirenzepine
48. Function of nicotinic receptors in the CNS
49. Automated image registration: II. Intersubject validation of linear and nonlinear models